The combination therapy of the cancer-vaccine therapy and the preoperative chemoradiotherapy for rectal cancer (phase I trial)

这项研究是对晚期直肠癌患者进行的一期临床试验，包括术前放化疗和肿瘤特异性疫苗治疗。这项研究的目的是检查这种联合疗法的安全性。遗憾的是，尽管这项临床试验的方案或知情同意文件是在第一年准备的，但这项临床试验不能在研究期内进行。然而，在未来的临床试验中，分析晚期直肠癌患者术前放化疗的数据是有用的，或者不仅可以定位和教育医生，还可以定位和教育本研究的护士、药剂师和医疗技术人员。

This study was a phase I clinical trial of the therapy, combined preoperative chemoradiotherapy with tumor-specific vaccine therapy, for the cases with advanced rectal cancer. The purpose of this study was to examine the safety of this combination therapy. Unfortunately, this clinical trial, however the protocol of this clinical trial or the document of informed consent was prepared in the first year, was not able to be performed within research periods.It was useful, however, in performing this clinical trial in future, to analyze the data of the advanced rectal cancer cases performed preoperative chemoradiotherapy, or to locate and educate not only medical doctors but also nurses, pharmacists, and medical technicians for this study.